Treatment options for status epilepticus

Current Opinion in Pharmacology

Volumn 3, Issue 1, 2003, Pages 6-11

  Lowenstein, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DIAZEPAM; FOSPHENYTOIN SODIUM; HALOTHANE; HYPERTENSIVE AGENT; INHALATION ANESTHETIC AGENT; KETAMINE; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

ALGORITHM; DRUG COST; DRUG HALF LIFE; EMERGENCY; EPILEPTIC STATE; EPILEPTOGENESIS; HUMAN; HYPOTENSION; INCIDENCE; INJECTION SITE; LIPID METABOLISM; PANCREATITIS; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; SKIN MANIFESTATION;

AMBULATORY CARE; ANIMALS; ANTICONVULSANTS; CLINICAL TRIALS; HUMANS; STATUS EPILEPTICUS;

EID: 0037302995     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00005-X     Document Type: Review

References (49)

1. DeLorenzo R, Hauser W, Towne A, Boggs J, Pellock J, Penberthy L, Garnett L, Fortner C,Ko D: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:12029-1035.
2. Aminoff M, Simon R: Status epilepticus: causes clinical features and consequences in 98 patients. Am J Med 1980, 69:657-666.
3. Alldredge B, Lowenstein D, Simon R: Status epilepticus in the 1980s: etilogy, treatment and outcome. Neurology 1990, 40(Suppl 1):297.
4. DeLorenzo R, Pellock J, Towne A, Boggs J: Epidemiology of status epilepticus. J Clin Neurophys 1995, 12:316-325.
5. Walker M: The epidemiology and management of status epilepticus. Curr Opin Neurol 1998; 11:149-154.
6. Recommendation of the Epilepsy Foundation of America's Working Group on Status Epilepricus: Treatment of convulsive status epilepticus. J Am Med Assoc 1993, 270:854-589.
7. Lowenstein D, Bleck T, MacDonald R: It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
8. Towne A, Pellock J, Ko D, DeLorenzo R: Determinants of mortality in status epilepticus. Epilepsia 1994; 35:27-34.
9. Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA: Long-term mortality after a first episode of status epilepticus. Neurology 2002, 58:537-541.
10. Bleck TP: Advances in the management of refractory status epilepticus. Crit Care Med 1993, 21:955-957.
11. Lowenstein D, Alldredge B: Current concepts: status epilepticus. N Engl J Med 1998, 338:970-976.
12. Coulter DA, DeLorenzo RJ: Basic mechanisms of status epilepticus. Adv Neurol 1999, 79:725-733.
13. A receptors. J Neurosci 1997, 17:7532-7540.
14. A receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998, 4:1166-1172.
15. Borris DJ, Bertram EH, Kapur J: Ketamine controls prolonged status epilepticus. Epilepsy Res 2000, 42:117-122.
16. Prasad A, Williamson JM, Bertram EH: Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann Neurol 2002, 51:175-181.
17. Mazarati AM, Wasteriain Cg: N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999, 265:187-190.
18. Walton NY, Treiman CG: Motor and electroencephalographic response of refractory experimental status epilepticus in rats diazepam. Brain Res 1991, 553:97-104.
19. Bleck TP: Refractory status epilepticus in 2001. Arch Neurol 2002, 59:188-189.
20. Treiman D, Meyers P, Walton N, Collins J, Colling C, Rowan A, Handforth A, Faught E, Calabrese V, Uthman B et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792-798.
21. Cock HR, Schapira AH: A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM 2002, 95:225-231.
22. Alldredge B, Gelb A, Isaacs S, Corry M, AllenF, Ulrich S, Gottwald M, O'Neil N, Neuhaus J, Segal M et al.: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.
23. Kugler AR, Knapp LE, Eldon MA: Attainment of therapeutic phemytoin concentrations following administration of loading doses of fosphenytoin: a meta-analysis. Neurology 1996, 46(Suppl):A176.
24. Heafield MT: Managing status epilepticus. New drug offers real advantages. BMJ 2000, 320:953-954.
25. Touchette D, Rhoney D: Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy 2000, 20:908-916.
26. DeToledo J, Ramsay R: Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased cost. Drug Saf 2000, 22:459-466.
27. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Ver-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988, 38:1035-1040.
28. Sinha S, Naritoku D: Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000, 55:722-724.
29. Sheth R, Gidal B:Intravenous valproic acid for myoclonic status epilepticus. Neurology 2000, 54:1201.
30. Hodges BM, Mazur JE: Intravenous valproate in status epilepticus. Ann Pharmacother 2001, 35:1465-1470.
31. Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ: Use of intravenous valproate in three pediatric patients with nonconvulsive of convulsive status epilepticus. Ann Pharmacother 1999, 33:579-584.
32. Kaplan PW: Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999, 30:1-4.
33. Lowe M, DeToledo J, Vilavizza N, Ramsay R: Efficacy, safety, and tolerability of fast i.v. loading of valproate in patients with seizures and status epilepticus [abstract]. Epilepsia 1998, 39(Suppl 6):235.
34. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D: Intravenous valproate in pediatric epilapsy patients with refractory status epilepticus. Neurology 2000, 54:2188-2189.
35. Wheless J, Venkataraman R, Wunsiedler U, Wenzel D: Intravenous valproate [abstract]. Epilepsia 1998, 39(Suppl 6):50.
36. Walker MC, Howard RS, Smith SJ, Miller DH, Shorvon SD, Hirsch NP: Diagnosis and treatment of status epilepticus on a neurological intensive care unit. QJM 1996, 89:913-920.
37. Sheth RD, Gidal BE: Refractory status epilepticus: response to ketamine. Neurology 1998, 51:1765-1766.
38. Lee SR, Kim SP, Kim JE: Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett 2000, 281:183-186.
39. Lee WT, Shen YZ, Chang C: Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magenetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Nueroscience 2000, 95:89-95.
40. Koh S, Jensen FE: Topiramate blocks perinatal hypoxia-induced siezures in rat pups. Ann Neurol 2001, 50:366-372.
41. Alldredge BK, Gelb AM, Lowenstein DH: The effect of prehospital treatment of status epilepticus on subsequent patient management [abstract]. Neurology 1992, 42(Suppl 3):400.
42. Alldredge B, Gelb A, Isaacs M, Ulrich S, Allen F, Segal M, Neuhaus J, Lowenstein D: Evaluation of out-of-hospital therapy for status epilepticus [abstract]. Epilepsia 1995, 36(Suppl 4):44.
43. Lowenstein D, Alldredge B, Allen F, Neuhaus J, Corry M, Gottwald M, O'Neil N, Ulrich S, Isaacs S, Gelb A: The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials 2001, 22:1-20.
44. Yaffe K, Lowenstein DH: Prognostic factors of pentobarbial therapy for refractory generalized status epilepticus. Neurology 1993, 49:895-900.
45. Brown L, Levin G: The role of propofol in refractory status epilepticus. Annals Pharmacol 1998, 32:1053-1059.
46. Fountain N, Adams R: Midazolam treatment of acute and refractory status eplicpticus. Clin Pharmacol 1999, 22:261-267.
47. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA: Continous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57:1036-1042.
48. Stecker M, Kramer T, Raps E, O'Meeghan R, Dulaney E, Skaar D: Treatment of refractory status epilepticus with propofol: clinical pharmacokinetic findings. Epilepsia 1998, 39:18-26.
49. Claassen J, Hirsch LJ, Emerson RG, Mayer SA: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43: 146-153.